133 related articles for article (PubMed ID: 36820587)
21. Effects of surgery on survival of elderly patients with stage I small-cell lung cancer: analysis of the SEER database.
Li Y; Hu S; Xie J; Zhang X; Zong Y; Xu B; Li C
J Cancer Res Clin Oncol; 2019 Sep; 145(9):2397-2404. PubMed ID: 31302755
[TBL] [Abstract][Full Text] [Related]
22. Choice of surgical procedure - lobectomy, segmentectomy, or wedge resection - for patients with stage T1-2N0M0 small cell lung cancer: A population-based study.
Liu Y; Shan L; Shen J; Liu L; Wang J; He J; He Q; Jiang L; Guo M; Chen X; Zeng H; Xia X; Peng G; Liang W; He J
Thorac Cancer; 2019 Apr; 10(4):593-600. PubMed ID: 30854808
[TBL] [Abstract][Full Text] [Related]
23. Effect of surgery on survival in patients with stage III N2 small cell lung cancer: propensity score matching analysis and nomogram development and validation.
Chai Y; Ma Y; Feng W; Lu H; Jin L
World J Surg Oncol; 2021 Aug; 19(1):258. PubMed ID: 34461929
[TBL] [Abstract][Full Text] [Related]
24. Predictors of prognosis of synchronous brain metastases in small-cell lung cancer patients.
Reddy SP; Dowell JE; Pan E
Clin Exp Metastasis; 2020 Aug; 37(4):531-539. PubMed ID: 32500410
[TBL] [Abstract][Full Text] [Related]
25. Validation of the AJCC 8th lung cancer staging system among patients with small cell lung cancer.
Abdel-Rahman O
Clin Transl Oncol; 2018 Apr; 20(4):550-556. PubMed ID: 28808860
[TBL] [Abstract][Full Text] [Related]
26. [Second primary cancers after small-cell lung cancer].
Soria JC; Bréchot JM; Lebeau B; Rochemaure J
Bull Cancer; 1997 Aug; 84(8):800-6. PubMed ID: 9339185
[TBL] [Abstract][Full Text] [Related]
27. Development and validation of nomograms for predicting survival of elderly patients with stage I small-cell lung cancer.
Yang Y; Sun S; Wang Y; Xiong F; Xiao Y; Huang J
Bosn J Basic Med Sci; 2021 Oct; 21(5):632-641. PubMed ID: 33577444
[TBL] [Abstract][Full Text] [Related]
28. Prognostic effect of liver metastasis in lung cancer patients with distant metastasis.
Ren Y; Dai C; Zheng H; Zhou F; She Y; Jiang G; Fei K; Yang P; Xie D; Chen C
Oncotarget; 2016 Aug; 7(33):53245-53253. PubMed ID: 27449299
[TBL] [Abstract][Full Text] [Related]
29. Incidence of Second Malignancy after Successful Treatment of Limited-Stage Small-Cell Lung Cancer and Its Effects on Survival.
Kono M; Allen PK; Lin SH; Wei X; Jeter MD; Welsh JW; Cox JD; Komaki R
J Thorac Oncol; 2017 Nov; 12(11):1696-1703. PubMed ID: 28804012
[TBL] [Abstract][Full Text] [Related]
30. The applicability of the proposed IASLC staging revisions to small cell lung cancer (SCLC) with comparison to the current UICC 6th TNM Edition.
Ignatius Ou SH; Zell JA
J Thorac Oncol; 2009 Mar; 4(3):300-10. PubMed ID: 19156001
[TBL] [Abstract][Full Text] [Related]
31. Trends in the risk and burden of second primary malignancy among survivors of smoking-related cancers in the United States.
Adjei Boakye E; Buchanan P; Hinyard L; Osazuwa-Peters N; Simpson MC; Schootman M; Piccirillo JF
Int J Cancer; 2019 Jul; 145(1):143-153. PubMed ID: 30613963
[TBL] [Abstract][Full Text] [Related]
32. Risk and survival of second primary malignancies following diagnosis of gastric mucosa-associated lymphoid tissue lymphomas: A population-based study.
Yang Y; Yang Y; Yan S
Curr Probl Cancer; 2021 Dec; 45(6):100735. PubMed ID: 33867153
[TBL] [Abstract][Full Text] [Related]
33. Comparison of cisplatin/etoposide versus carboplatin/etoposide concurrent chemoradiation therapy for limited-stage small cell lung cancer (LS-SCLC) in the elderly population (age >65 years) using national SEER-Medicare data.
Kim E; Biswas T; Bakaki P; Dowlati A; Sharma N; Machtay M
Pract Radiat Oncol; 2016; 6(5):e163-e169. PubMed ID: 27142494
[TBL] [Abstract][Full Text] [Related]
34. Predictors for survival in patients with bone metastasis of small cell lung cancer: A population-based study.
Xue M; Chen G; Chen X; Hu J
Medicine (Baltimore); 2021 Aug; 100(34):e27070. PubMed ID: 34449503
[TBL] [Abstract][Full Text] [Related]
35. Survival disparities for second primary malignancies diagnosed among childhood cancer survivors: A population-based assessment.
Brown AL; Arroyo VM; Agrusa JE; Scheurer ME; Gramatges MM; Lupo PJ
Cancer; 2019 Oct; 125(20):3623-3630. PubMed ID: 31251393
[TBL] [Abstract][Full Text] [Related]
36. Propensity score matched analysis for the role of surgery in stage Ⅲ small cell lung cancer based on the eighth edition of the TNM classification: a population study of the US SEER database and a Chinese hospital.
Gao L; Shen L; Wang K; Lu S
Lung Cancer; 2021 Dec; 162():54-60. PubMed ID: 34739854
[TBL] [Abstract][Full Text] [Related]
37. The prognostic risk stratification model for metastatic small-cell lung cancer: An analysis of the SEER database.
Qie S; Shi H; Wang F; Liu F; Zhang X; Li Y; Sun X
Medicine (Baltimore); 2022 Oct; 101(42):e31000. PubMed ID: 36281112
[TBL] [Abstract][Full Text] [Related]
38. Risk of second primary malignancy after minor salivary gland cancer: A Surveillance, Epidemiology, and End Results database analysis.
Yang J; Wei R; Song X; Sun X; Wang H; Liu Q; Hu L; Yu H; Wang D
Head Neck; 2021 Jun; 43(6):1769-1779. PubMed ID: 33590552
[TBL] [Abstract][Full Text] [Related]
39. Prognosis of Hepatocellular Carcinoma Among Cancer Survivors with Other Types of Primary Tumors.
Bian X; He X; Yang L; Wu W; Li L
Dig Dis Sci; 2020 Jul; 65(7):2140-2147. PubMed ID: 31673904
[TBL] [Abstract][Full Text] [Related]
40. Effects of chemotherapy on survival of elderly patients with small-cell lung cancer: analysis of the SEER-medicare database.
Caprario LC; Kent DM; Strauss GM
J Thorac Oncol; 2013 Oct; 8(10):1272-81. PubMed ID: 24457238
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
